secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001683168-25-000357
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma appoints Michel Roy as Chief Commercial Officer
------------------------------------------------------------------

- Michel Roy appointed CCO effective Jan 13, 2025; initial base salary of $400,000 CAD annually.
- Severance of $500,000 CAD payable if terminated without cause, plus minimum statutory notice.
- Roy previously led Canadian ops of Shilpa Medicare (2020-2024) and was VP at Intas Pharmaceuticals (2014-2020).
- Responsibilities include overseeing commercial strategy, sales, marketing, and business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825000357/0001683168-25-000357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825000357/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer